Zuclopenthixol Hydrochloride

盐酸珠氯噻嗪

Report date: 2022/09/07 17:52:11
NME

Base Information

Drug NameZuclopenthixol Hydrochloride
Drug Alias NameZuclopentixol盐酸珠氯噻醇Clopenthixol HydrochlorideZuclopenthixolumzuclopenthixol +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor antagonistsDopamine D2 receptor antagonists
TargetsDopamine D1 receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaBipolar Disorder
Global Approved IndicationsSchizophreniaBipolar Disorder
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1962/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesLundbeck Pharmaceuticals (Tianjin) Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN05AF05
Related LinksWikipediaDrugBankKEGG